Gresham makes 12x return from drug company
Buyout firm Gresham Private Equity has sold Penn Pharmaceuticals after increasing profits tenfold.
3 January 2013•1 min read
Buyout firm Gresham Private Equity has sold Penn Pharmaceuticals after increasing profits tenfold.
